After 6 years of delivering practice management tools and solutions for veterinary teams, veterinaryteambrief.com closed at the end of 2018. Veterinary Team Brief archived content and Social Media Calendars are accessible on cliniciansbrief.com. For more information about accessing Veterinary Team Brief content, click here.

Melarsomine

May 2018

Sign in to Print/View PDF

Melarsomine

Arsenical Antiparasitic (Systemic Drug)

Prescriber Highlights

  • Organic arsenical adulticide to treat heartworm disease in dogs
  • American Heartworm Society recommends a 3-dose protocol (except for dogs with caval syndrome) after treatment with doxycycline and a macrocyclic lactone
Uses, Indications
  • Four weeks of doxycycline therapy and administration of a macrocyclic lactone is recommended before melarsomine administration
  • Indicated in the treatment of stabilized class I (mild), II (moderate), and III (severe) heartworm disease caused by immature (ie, postlarval, stage L5) to mature adult Dirofilaria immitis infections in dogs
Contraindications, Precautions, Warnings
  • Contraindications

Not recommended for use in cats or patients with class IV (ie, caval syndrome) heartworm disease

  • Precautions

Older dogs may be more susceptible than younger dogs to adverse effects

  • Warnings

Not for IV or SQ use because significant toxicity or tissue damage may occur; large breeds requiring larger volumes may be more susceptible to tissue damage

Side Effects
  • Injection site reactions (eg, pain, swelling, tenderness, reluctance to move) occur in approximately one third of patients 
  • Coughing/gagging, depression, lethargy, anorexia, inappetence, fever, lung congestion, vomiting, and hypersalivation
Drug Interactions
  • Aspirin may complicate therapy; concurrent use is not recommended
  • CNS depressant drugs may cause additive side effects or increase the incidence of the effects
Monitoring
  • Side effects, which include signs of thromboembolism
  • Cardiac biomarkers (eg, troponin I, creatine kinase-MB isoenzyme) may be useful to monitor the effects of worms and adulticide treatment on the heart
  • Test for microfilaria 30 days after the last melarsomine dose
  • Perform an antigen test 6 months after the last melarsomine dose
Client Information
  • Strict exercise restriction after dosing is essential
  • Because of the seriousness of the disease and the potential for morbidity and mortality associated with treatment, clients should give their informed consent before treatment begins
Dosage Forms
  • The following product is labeled for veterinary use:
    • Melarsomine dihydrochloride powder for injection: 50 mg/vial

Compiled and summarized from Plumb’s® Veterinary Drugs by Shannon Palermo, VMD

Information about this drug was adapted from Plumb’s® Veterinary Drugs. Further details and more therapeutics can be found with a subscription at plumbsveterinarydrugs.com

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.

Practice Tools

Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© 2018 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Privacy Policy (Updated 05/08/2018) Terms of Use (Updated 05/08/2018)